DEF 14AThe Ballot
Janux Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2024 · 2y ago · Accession 0000950170-24-049873
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- DEF 14A
- Filing date
- Apr 29, 2024
- Report date
- Jun 26, 2024
- Document
- janx_def_14a_2024_non_xb.htm
- Size
- 1.4 MB